Ching‐Yu Wang

National Taiwan University Hospital

Papers

1

Total Citations

6

H-Index

1

About

Ching-Yu Wang is a leading figure in the emerging field of noninvasive cardiac radioablation, a revolutionary treatment for ventricular tachycardia. His work bridges radiation oncology and cardiology, focusing on the precise dosimetric planning required to safely deliver high-dose radiation to arrhythmogenic cardiac tissue. Wang’s most cited study provides a critical dosimetric comparison between linear accelerator-based systems and the robotic CyberKnife platform for this delicate procedure. By systematically evaluating target coverage and organ-at-risk sparing, his research offers essential guidance for clinicians selecting the optimal technology to maximize treatment efficacy while minimizing collateral damage to the lungs and esophagus. This work, published in 2023 and already garnering significant attention, underscores his role in standardizing a novel, noninvasive alternative to traditional catheter ablation. Wang’s contributions are helping to define the technical benchmarks for a therapy that promises to transform the management of refractory ventricular tachycardia, making him a key voice in the convergence of radiation physics and interventional electrophysiology.

Research Focus

Key Achievements

1
H-Index
1
Papers
6
Total Citations
6
Avg Citations/Paper
🏆 Most Cited Paper
Noninvasive cardiac radioablation for ventricular tachycardia: dosimetric comparison between linear accelerator- and robotic CyberKnife-based radiosurgery systems
6 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 9
🏛 Institutions: National Taiwan University Hospital

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago